Clorgiline
From Wikipedia, the free encyclopedia
 |
|
|
Clorgiline
|
|
| Systematic (IUPAC) name | |
| N-[3-(2,4-dichlorophenoxy)propyl]-N-methyl- prop-2-yn-1-amine |
|
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C13H15Cl2NO |
| Mol. mass | 272.17 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Clorgiline (INN) or clorgyline is an inhibitor of monoamine oxidase type A, structurally related to pargyline. It has antidepressant activity, and may potentially be useful in the treatment of Parkinson's disease.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
